ASPEN FERNANDO: Open Payments
NPI 1013782150 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,469 in 51 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,574 · 2025 $1,469
Food & beverage: $1,469
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $313 |
| Novartis Pharmaceuticals Corporation | 12 | $239 |
| Amgen Inc. | 8 | $210 |
| Boston Scientific Corporation | 5 | $192 |
| E.R. Squibb & Sons, L.L.C. | 7 | $188 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $127 |
| Esperion Therapeutics, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $49 |
| PFIZER INC. | 1 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $34 |
Products named: Kerendia, LEQVIO, REPATHA, CAMZYOS, LifeVest, General - Atherectomy, JETSTREAM SC, NEXLETOL.
Industry payments across CA — which companies pay providers there.
